BackTevogen Bio Holdings - Warrants (14/02/2029) Overview

Tevogen Bio Holdings - Warrants (14/02/2029) Operating Income

Tevogen Bio Holdings - Warrants (14/02/2029)'s operating income is $-21M.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$-5662376.00
↑ 4% YoY

As of Jun 30, 2026

Annual Operating Income (TTM)

$-21402928.00
↓ 31.51% YoY

Trailing 12 months ending Jun 30, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Tevogen Bio Holdings - Warrants (14/02/2029) (TVGNW) FAQ

As of the most recent data (June 2026), TVGNW shows a operating income of $-21M. That compares with $-31M in the prior-year period — up 31.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TVGNW's operating income is now $-21M (was $-31M) — a 31.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Tevogen Bio Holdings - Warrants (14/02/2029) is outperforming or lagging.

Tracking TVGNW's operating income over time shows whether Tevogen Bio Holdings - Warrants (14/02/2029) is scaling, shrinking, or reshaping that part of the business. The current reading is $-21M That compares with $-31M in the prior-year period — up 31.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Tevogen Bio Holdings - Warrants (14/02/2029)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-21M) with ownership activity and broader fundamentals.